Volume | 0 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Anzu Special Acquisition Corporation I | ANZUU | NASDAQ | Trust |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
7.09 | 7.09 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | 7.09 | USD |
Anzu Special Acquisition Corporation I Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
170.85M | 42.50M | - | 0 | 19.23M | 0.45 | 8.88 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Anzu Special Acquisition...
Date | Time | Source | Heading |
---|---|---|---|
3/04/2024 | 08:23 | Edgar (US Regulatory) | Form 8-K - Current report |
1/18/2024 | 16:09 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
1/17/2024 | 15:16 | Edgar (US Regulatory) | Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:.. |
9/29/2023 | 20:11 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
9/27/2023 | 15:24 | Edgar (US Regulatory) | Form 8-K - Current report |
9/27/2023 | 15:10 | Business Wire | Anzu Special Acquisition Corp I Stockholders Approve.. |
9/15/2023 | 08:03 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
9/15/2023 | 08:02 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
9/15/2023 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
9/15/2023 | 05:02 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
9/14/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
9/05/2023 | 15:50 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
ANZUU Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
Envoy Medical Corporation manufactures and markets an implantable hearing aid device. Its products include hearing aids; middle ear implants that include esteem hearing implants; bone conduction devices; and cochlear implants, such as acclaim cochlear implants. The company offers hearing prosthetics under the Esteem brand name. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was incorporated in 1995 and is based in White Bear Lake, Minnesota. |